your badges 52W Range $10–$11 100% of range Analyst Rating · Price Target · P/E · ROE -82.4% Net Profit Margin ·

DMAA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $10.89
Market Cap (MRQ) $117M
ROE -82.4%
52W Range $10–$11

DMAA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend DMAA 5Y avg Peer Median Verdict
P/B (MRQ) -16.1 · · ·
Price / Cash Flow -216.5 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 6
Metric Trend 2025
SG&A Expense $3M
Operating Income $-3M
Interest Income $9M
Other Non-op $9M
Net Income $6M
EBITDA $-3M
Balance Sheet 12
Metric Trend 2025
Cash & Equivalents $6.1K
Prepaid Expense $6.1K
Current Assets $12.2K
Total Assets $240M
Accounts Payable $222.2K
Current Liabilities $376.2K
Total Liabilities $7M
Common Stock $1.1K
Retained Earnings $-7M
Stockholders' Equity $-7M
Liabilities + Equity $240M
Shares Outstanding 10,717,143
Cash Flow 3
Metric Trend 2025
Operating Cash Flow $-539.2K
Investing Cash Flow $-231M
Financing Cash Flow $232M
Profitability 2
Metric Trend 2025
ROA 4.9%
ROE -82.4%
Liquidity & Solvency 2
Metric Trend 2025
Current Ratio 0.0
Quick Ratio 0.0
Per Share 2
Metric Trend 2025
Book Value / Share $-0.68
Cash / Share $0.00
Valuation (TTM) 4
Metric Trend 2025
Net Income TTM $6M
Market Cap $111M
P/B -15.3
P / Cash Flow -206.2

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-31
Net Income $6M ·

Institutional owners (13F) 25 filers · $124.5M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 25
Value held $124.5M
New positions 1
Exited positions 17
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
1 (-4 vs prior Q) 17 (+11 vs prior Q) 3 (-4 vs prior Q) 14 (+7 vs prior Q) -10.7M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Karpus Management, Inc. $26,708,251 2,507,817 21.45% Shares
MIZUHO SECURITIES USA LLC $21,930,113 2,069,605 17.61% Shares
Polar Asset Management Partners Inc. $12,204,900 1,146,000 9.80% Shares
WOLVERINE ASSET MANAGEMENT LLC $8,861,790 832,093 7.12% Shares
HIGHBRIDGE CAPITAL MANAGEMENT LLC $8,616,425 809,054 6.92% Shares
First Trust Capital Management L.P. $8,375,788 786,459 6.73% Shares
HEIGHTS CAPITAL MANAGEMENT, INC $6,902,084 648,083 5.54% Shares
Westchester Capital Management, LLC $6,196,063 581,790 4.98% Shares
MIZUHO SECURITIES USA LLC $5,402,472 542,962 4.34% Shares
ATW SPAC MANAGEMENT LLC $5,135,000 500,000 4.12% Shares
ARISTEIA CAPITAL, L.L.C. $3,727,500 350,000 2.99% Shares
SONA ASSET MANAGEMENT (US) LLC $1,733,767 162,795 1.39% Shares
Clear Street Group Inc. $1,645,529 382,440 1.32% Shares
Logan Stone Capital, LLC $1,171,063 109,959 0.94% Shares
CLEAR STREET LLC $1,148,673 112,615 0.92% Shares
TORONTO DOMINION BANK $1,065,000 100,000 0.86% Shares
Meteora Capital, LLC $1,041,964 97,837 0.84% Shares
Quarry LP $698,118 65,551 0.56% Shares
GEODE CAPITAL MANAGEMENT, LLC $663,207 62,273 0.53% Shares
JPMORGAN CHASE & CO $531,339 49,891 0.43% Shares
Dakota Wealth Management $387,660 36,400 0.31% Shares
Lineage Point Capital LP $339,096 31,840 0.27% Shares
GLAZER CAPITAL, LLC $10,649 999,899 0.01% Shares
MORGAN STANLEY $298 28 0.00% Shares
HRT FINANCIAL LP $196 18,483 0.00% Shares

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Drugs Made In America Acquisition LLC, Lynn Stockwell March 3, 2025 12.50% Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 6 insiders · 2 officers · 4 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Lynn Stockwell CEO and Exe. Chair of Board Feb. 18, 2025 P 4,188,780 0 0 $0
Glenn C. Worman CFO Jan. 29, 2025 J 100,000 0 0 $0
Catherine Do Director Jan. 29, 2025 J 100,000 0 0 $0
Myron W. Shulgan Director Jan. 29, 2025 J 100,000 0 0 $0
Sridhar G. Prasad Director Jan. 29, 2025 J 100,000 0 0 $0
Drugs Made In America Acquisition LLC 10% owner Feb. 18, 2025 P 4,188,780 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-K filed Apr 15, 2026